These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 26000311

  • 1. Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
    Ishida M, Kitaura H, Kimura K, Sugisawa H, Aonuma T, Takada H, Takano-Yamamoto T.
    J Immunol Res; 2015; 2015():132765. PubMed ID: 26000311
    [Abstract] [Full Text] [Related]

  • 2. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K.
    J Immunol; 2005 Aug 01; 175(3):1956-64. PubMed ID: 16034140
    [Abstract] [Full Text] [Related]

  • 3. Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.
    Kitaura H, Ishida M, Kimura K, Sugisawa H, Kishikawa A, Shima K, Ogawa S, Qi J, Shen WR.
    Anal Cell Pathol (Amst); 2018 Aug 01; 2018():8047610. PubMed ID: 29666781
    [Abstract] [Full Text] [Related]

  • 4. IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
    Saeed J, Kitaura H, Kimura K, Ishida M, Sugisawa H, Ochi Y, Kishikawa A, Takano-Yamamoto T.
    Immunol Lett; 2016 Jul 01; 175():8-15. PubMed ID: 27154248
    [Abstract] [Full Text] [Related]

  • 5. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS, Ma CJ, Kim DS, Ma JY.
    J Med Food; 2011 Nov 01; 14(11):1439-47. PubMed ID: 21883017
    [Abstract] [Full Text] [Related]

  • 6. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
    Kimura K, Kitaura H, Fujii T, Hakami ZW, Takano-Yamamoto T.
    FEMS Immunol Med Microbiol; 2012 Mar 01; 64(2):219-27. PubMed ID: 22067001
    [Abstract] [Full Text] [Related]

  • 7. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
    Chang CC, Tsai YH, Liu Y, Lin SY, Liang YC.
    Rheumatology (Oxford); 2015 Oct 01; 54(10):1913-22. PubMed ID: 25998451
    [Abstract] [Full Text] [Related]

  • 8. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W, Dou H, Liu X, Sun L, Hou Y.
    Clin Exp Pharmacol Physiol; 2012 Oct 01; 39(10):886-93. PubMed ID: 23013134
    [Abstract] [Full Text] [Related]

  • 9. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, Du SX.
    Cell Physiol Biochem; 2012 Oct 01; 30(1):123-36. PubMed ID: 22759961
    [Abstract] [Full Text] [Related]

  • 10. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L, Zhou K, Wang S, Zhang H, Fan N, Li J, Tan X, Hu L, Fan X.
    Cell Physiol Biochem; 2018 Oct 01; 48(5):2123-2133. PubMed ID: 30110702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways.
    van Heerden B, Kasonga A, Kruger MC, Coetzee M.
    Nutrients; 2017 Apr 28; 9(5):. PubMed ID: 28452958
    [Abstract] [Full Text] [Related]

  • 13. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW.
    Cell Death Differ; 2004 Jul 28; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [Abstract] [Full Text] [Related]

  • 14. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ, Kim KN, Heo SJ, Han SC, Kim J, Ko YJ, Kang HK, Yoo ES.
    Biochem Biophys Res Commun; 2013 May 17; 434(4):892-7. PubMed ID: 23611776
    [Abstract] [Full Text] [Related]

  • 15. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
    J Cell Physiol; 2009 Dec 17; 221(3):618-28. PubMed ID: 19653230
    [Abstract] [Full Text] [Related]

  • 16. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
    Fujii T, Kitaura H, Kimura K, Hakami ZW, Takano-Yamamoto T.
    Bone; 2012 Oct 17; 51(4):771-80. PubMed ID: 22776139
    [Abstract] [Full Text] [Related]

  • 17. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.
    Tao H, Okamoto M, Nishikawa M, Yoshikawa H, Myoui A.
    PLoS One; 2011 Oct 17; 6(8):e23199. PubMed ID: 21886782
    [Abstract] [Full Text] [Related]

  • 18. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
    Kim JY, Park SH, Oh HM, Kwak SC, Baek JM, Lee MS, Rho MC, Oh J.
    Molecules; 2014 Nov 12; 19(11):18465-78. PubMed ID: 25397737
    [Abstract] [Full Text] [Related]

  • 19. CaMKII(δ) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway.
    Lu DZ, Dong W, Feng XJ, Chen H, Liu JJ, Wang H, Zang LY, Qi MC.
    Mol Cell Endocrinol; 2020 May 15; 508():110791. PubMed ID: 32173349
    [Abstract] [Full Text] [Related]

  • 20. Ethanol increases osteoclastogenesis associated with the increased expression of RANK, PU.1 and MITF in vitro and in vivo.
    Iitsuka N, Hie M, Nakanishi A, Tsukamoto I.
    Int J Mol Med; 2012 Jul 15; 30(1):165-72. PubMed ID: 22576626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.